Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 4/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | HTR6 | P50406 | 1/20 | 0.58 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.52 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.52 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.52 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.52 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.52 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.52 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26530291 | 0.88 | GAA (0.68) | FFAR4SMN1; SMN2LMNACYP19A1GAA | |
| SCHEMBL6341473 | 0.85 | FFAR4 (0.56) | FFAR4SMN1; SMN2LMNACYP19A1MAPK1 | |
| SCHEMBL28575423 | 0.84 | KIF11 (0.65) | FFAR4SMN1; SMN2LMNACYP19A1GAA | |
| SCHEMBL28577596 | 0.82 | FFAR4 (0.53) | FFAR4SMN1; SMN2MAPTHDAC1HDAC8 | |
| SCHEMBL7577285 | 0.82 | FFAR4 (0.59) | FFAR4SMN1; SMN2LMNAGAAMAPT | |
| SCHEMBL7570513 | 0.81 | FFAR4 (0.64) | FFAR4SMN1; SMN2MAPK1MAPTHDAC1 | |
| SCHEMBL189753 | 0.81 | PIK3CD (0.78) | SMN1; SMN2LMNAGAAMAPK1MAPT | |
| SCHEMBL4822277 | 0.80 | SMN1; SMN2 (0.67) | FFAR4SMN1; SMN2LMNAHTR6CYP19A1 | |
| SCHEMBL6756075 | 0.79 | FFAR4 (0.68) | FFAR4SMN1; SMN2HDAC1HDAC8HDAC3 | |
| SCHEMBL14601690 | 0.79 | FFAR4 (0.68) | FFAR4SMN1; SMN2HDAC1HDAC8HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230322715-A1 | BROAD SPECTRUM ANTI-CANCER COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230322715-A1 | BROAD SPECTRUM ANTI-CANCER COMPOUNDS | YTHDF1, YTHDF3, YTHDF2 | FFAR4 2391/4885SMN1; SMN2 3408/4885LMNA 3852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.